Published in Health Business Week, September 16th, 2005
Under the terms of the agreement, the Biodesign Institute's Center for BioOptical Nanotechnology is purchasing CombiMatrix equipment and funding development of the synthesizer. CombiMatrix is granting technology rights and contributing expertise related to CombiMatrix technology, and CombiMatrix and the Institute will share revenue from commercialization of the peptide array synthesizer, peptide array products,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.